Held at the Johns Hopkins Bloomberg Center in Washington, DC, the 2024 symposium welcomed ~ 103 attendees who shared insights and assessed progress. It charted a collective course of action to combat the threat posed Read more…
Issue 5 of SF Pulse is out now! The issue highlights the following: A call to World Health Organization to expand its existing Prequalification of Medicines Programme, which helps ensure enforcement of quality standards for Read more…
Geneva, Switzerland | February 26, 2025 The Fight the Fakes Alliance is excited to extend the warmest welcome to Fondation Pierre Fabre and the Italian Center for Coordinated Research (CRC) in Precision Medicine and Chronic Read more…
This statement was delivered by the World Heart Federation on behalf of Fight the Fakes Alliance at the 156th session of the WHO Executive Board: Honourable Chair, Distinguished Delegates, The World Heart Federation, supported by Read more…
Issue 4 of SF Pulse is out now! The newest issue dives into five topics including: A deep dive into how Johnson & Johnson starts thinking about anti-counterfeiting needs well before the product launch. An Read more…
On October 3rd, FTFA was invited by the World Trade Organization to speak at a closed-door panel discussion about “Substandard, Falsified and Counterfeit Medical Products” alongside the World Health Organization and the World Customs Organization. Read more…
The Global Pharma Health Fund (GPHF), a non-profit organization supported by Merck KGaA, is pleased to announce the Special Edition 2024, featuring a new Minilab test for detecting the toxic antifreeze agents diethylene glycol (DEG) and Read more…
September 24, 2024, Location – Fight the Fakes Alliance is excited to announce and welcome the Université la Source Conakry as the newest member of the Alliance. Given that one-fifth of medicines in Africa are Read more…
Medical Product Alert N°3/2024: Falsified (contaminated) Oxymorphone Hydrochloride 40mg Alert Summary This WHO Medical Product Alert refers to one batch of falsified Oxymorphone Hydrochloride 40mg. The falsified product was detected in the unregulated supply chain Read more…
On July 31st, 24, BBC published an article on the devastating effects surrounding the online purchases of fake semaglutide – an active ingredient in legal drugs like Ozempic, a type 2 diabetes drug, and Wegovy, Read more…
Our third SF Pulse Issue is out! SF Pulse is a bi-monthly newsletter that aims to elevate important issues and relevant stories shaping the ongoing fight against substandard and falsified medical products (SFs). The newest Read more…
On Friday, 26th July, the FDA, FTFA member USP, and the Asia Pacific Economic Cooperation (APEC) announced the launch of the new web-based version of APEC’s Supply Chain Security (SCS) Toolkit, an essential resource designed Read more…
On July 12, 2024, the New York Times published an article on the rise of counterfeit Ozempic and highlighting the greater risk of buying drugs online. The article interviewed a member of Fight the Fake Read more…
On July 4, 2024, Swissinfo published an article on the growing problem of fake medicines on their front page. The article quotes a number of Fight the Fakes Alliance (FTFA) members including the International Federation Read more…
Fight the Fakes Alliance member, Adam Aspinall, recently attended the Global Health Security Conference in Sydney on behalf of Medicines for Malaria Venture (MMV). At the conference, a forum that engages stakeholders to help achieve Read more…
King’s College London Fight the Fakes will welcome Dr. Asma Buanz in its next webinar about SFs on Thursday, 20 June! The issue of substandard and fake medical products (SFs) has been on the rise Read more…
Our second SF Pulse Issue is out! SF Pulse is a bi-monthly newsletter that aims to elevate important issues and relevant stories shaping the ongoing fight against substandard and falsified medical products (SFs). Read the Read more…
King’s College London Fight the Fakes will host a webinar about the response to substandard and falsified (SF) medical products in francophone Sub-Saharan African countries with Raffaella Ravinetto, PharmD, PhD, Head of the Public Health Read more…
Chemin des Mines 9 1202 Geneva Switzerland
